Wouter Verhesen
- Molecular Biology
- Cancer Research top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Surgery
- Immunology
- Co-authors
- Stéphane HeymansBlanche SchroenRick van LeeuwenPaolo CaraiMelissa SwinnenJack P.M. CleutjensGeert C. van AlmenMarc A. M. J. van Zandvoort
- Topics
- MicroRNA in disease regulation (5 papers)Viral Infections and Immunology Research (4 papers)Cardiac Fibrosis and Remodeling (4 papers)
- Partner nations
- NetherlandsBelgiumGermany
In The Last Decade
Wouter Verhesen
16 papers receiving 864 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 554
- Cancer Research 411
- Cardiology and Cardiovascular Medicine 341
- Surgery 102
- Immunology 97
Countries citing papers authored by Wouter Verhesen
This map shows the geographic impact of Wouter Verhesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Verhesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Verhesen more than expected).
Fields of papers citing papers by Wouter Verhesen
This network shows the impact of papers produced by Wouter Verhesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Verhesen. The network helps show where Wouter Verhesen may publish in the future.
Co-authorship network of co-authors of Wouter Verhesen
This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Verhesen. A scholar is included among the top collaborators of Wouter Verhesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Verhesen. Wouter Verhesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 35 | |
| 3 | 23 | |
| 4 | 35 | |
| 5 | 133 | |
| 6 | 29 | |
| 7 | Osteoglycin increases cardiac inflammation by enhancing toll-like receptor 4 activation | 0 |
| 8 | 12 | |
| 9 | 93 | |
| 10 | 1 | |
| 11 | 57 | |
| 12 | Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure | 2 |
| 13 | Micro-RNA 146a: a new kid on the block in the pathophysiology of cardiac hypertrophy and hypertensive heart failure, and a promising therapeutic target | 1 |
| 14 | 168 | |
| 15 | 212 | |
| 16 | 41 | |
| 17 | First record of Phylloptychoceras (Ammonoidea) from the Maastrichtian type area, The Netherlands | 6 |
About Wouter Verhesen
Wouter Verhesen is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Critical Care and Intensive Care Medicine, having authored 17 papers that have together received 874 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Viral Infections and Immunology Research (4 papers) and Cardiac Fibrosis and Remodeling (4 papers). The work is most often cited by research in Cancer Research (411 citations), Cardiology and Cardiovascular Medicine (341 citations) and Molecular Biology (554 citations). Wouter Verhesen has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Stéphane Heymans, Blanche Schroen, Rick van Leeuwen, Paolo Carai, Melissa Swinnen, Jack P.M. Cleutjens, Geert C. van Almen, Marc A. M. J. van Zandvoort, Casper Eurlings and M. van de Vrie. Their work appears in journals such as Circulation Research, Scientific Reports and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.